Cancer care is entering a new age, transitioning from treatments that attack both cancerous and healthy cells at the same time, to more targeted, specialized therapies that address the root cause of cancer itself without damaging surrounding tissues. Biotech company... Read more
Obesity is the single largest health crisis facing the world today. More than one billion people worldwide are overweight or obese, accounting for 38% of the population. In the U.S., a full 68% of adults, or some 200 million people, are overweight. On average, obese... Read more
Subscribe: Apple Podcasts | RSSThere is massive consolidation occurring in the healthcare space right now, and as a result hospital systems are acting almost like private equity groups. They’re sucking up all of these once-independent primary care providers and... Read more
For Euclises, it’s simple. Without the work of John Talley, Ph.D., the world would not have Celebrex®, the blockbuster arthritis treatment that has generated in excess of $3.5 billion in sales for Pfizer. Or Dynastat®, an injectable COX-2 inhibitor that’s sold in... Read more
There’s been a lot of talk this week about the EpiPen, and for good reason. First developed in the 1970s, the EpiPen is a medical device that automatically injects a measured dose of adrenaline into the bloodstream, allowing for easy field treatment of allergic... Read more
It was 2008, and Jon Snyder wasn’t happy. He had spent 25 years building a career in medical device sales, specializing in products that used neurostimulation to help patients with a variety of conditions manage chronic pain. He had worked all over the world as a... Read more
